Bantleon acquires majority stake in Credit Suisse Investment Partners
Credit Suisse Investment Partners manages convertible bond funds with a volume of around CHF1 billion ($1.11 billion).
Keystone / Peter Klaunzer
The German-Swiss asset manager Bantleon is expanding its bond management. It is buying a 62% stake in Credit Suisse Investment Partners (CSIP) from Credit Suisse and UBS. A contract to this effect was signed in Zurich at the end of May.
This content was published on
2 minutes
Keystone-SDA
CSIP manages convertible bond funds with a volume of around CHF1 billion ($1.11 billion) in four mutual funds and one single-investor fund. In the future, the company will operate under the name Bantleon Convertible Experts AG, the parties announced in separate statements on Monday.
More
More
Who’s to blame for the demise of Credit Suisse?
This content was published on
The final months of the doomed Credit Suisse bank are a hot topic of discussion Switzerland. Who is to blame?
According to Bantleon, the long-standing minority shareholders will remain on board with their 38% stake. Meanwhile, the 62% stake acquired from Credit Suisse is housed in the asset management subsidiary of what was Switzerland’s second-largest bank.
As a result of the takeover, which is still subject to approval by the Swiss Financial Market Supervisory Authority (FINMA), Bantleon’s managed assets will grow to around CHF24 billion and administered assets to around CHF38 billion.
Adapted from German by DeepL/dkk/ac
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Milei orders Argentina’s withdrawal from the World Health Organization
This content was published on
Argentina’s president, Javier Milei, has announced plans to pull the country out of the Geneva-headquartered World Health Organization (WHO).
‘Europe’ initiative halts signature collection to focus on Swiss-EU treaty
This content was published on
The initiative sought to embed Swiss-EU relations in the Federal Constitution, but the organisers have now stopped signature collection.
Swiss study sheds light on link between obesity and metabolic diseases
This content was published on
ETH Zurich researchers collected cells from overweight individuals to identify biological markers that raise the risk of metabolic diseases.
Swiss retail sector sees slight decline despite strong online sales
This content was published on
Black Friday, which performed well in some areas of Switzerland, and Christmas sales could not make up for the losses of previous months.
Over 6,000 Swiss companies go bankrupt but start-ups see growth
This content was published on
Switzerland recorded a spike in bankruptcies last year, but there was also a rise in new start-ups. Trends varied significantly by region and sector.
Basel greenlights funding for Eurovision Village 2025
This content was published on
MCH Group Ltd. is set to receive CHF1 million ($1.1 million) for the Eurovision Village at the Eurovision Song Contest 2025 in Basel.
Geneva researchers discover potential for targeted cancer drug delivery
This content was published on
Researchers in Geneva have discovered how some bacteria inject dangerous enzymes into cells, potentially enabling targeted drug delivery to cancer cells.
Macron denies involvement in Nestlé Waters scandal
This content was published on
French President Emmanuel Macron denied any “agreement” or “collusion” with the Swiss company Nestlé over the bottled water scandal on Tuesday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.